GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Cyclically Adjusted Price-to-FCF

Merus Labs International (Merus Labs International) Cyclically Adjusted Price-to-FCF : (As of May. 05, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Merus Labs International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Merus Labs International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Cyclically Adjusted Price-to-FCF Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Merus Labs International's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Cyclically Adjusted Price-to-FCF falls into.



Merus Labs International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Merus Labs International's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2017 is calculated as:

For example, Merus Labs International's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2017 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2017 (Change)*Current CPI (Mar. 2017)
=0.017/102.6337*102.6337
=0.017

Current CPI (Mar. 2017) = 102.6337.

Merus Labs International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200706 0.146 88.412 0.169
200709 -3.017 88.412 -3.502
200712 0.206 88.491 0.239
200803 -0.045 88.965 -0.052
200806 -0.142 91.177 -0.160
200809 0.506 91.414 0.568
200812 -0.394 89.518 -0.452
200903 0.081 90.071 0.092
200906 0.321 90.940 0.362
200909 0.669 90.624 0.758
200912 -0.637 90.703 -0.721
201003 -0.120 91.335 -0.135
201006 0.231 91.809 0.258
201009 -0.078 92.362 -0.087
201012 -0.042 92.836 -0.046
201103 -0.134 94.338 -0.146
201106 -0.230 94.654 -0.249
201109 -0.360 95.286 -0.388
201112 0.134 94.970 0.145
201203 0.024 96.155 0.026
201206 -0.134 96.076 -0.143
201209 0.074 96.392 0.079
201212 0.067 95.760 0.072
201303 0.095 97.103 0.100
201306 0.092 97.182 0.097
201309 0.078 97.419 0.082
201312 0.078 96.945 0.083
201403 0.067 98.604 0.070
201406 0.054 99.473 0.056
201409 0.040 99.394 0.041
201412 0.031 98.367 0.032
201503 0.114 99.789 0.117
201506 0.070 100.500 0.071
201509 0.022 100.421 0.022
201512 0.047 99.947 0.048
201603 0.045 101.054 0.046
201606 0.007 102.002 0.007
201609 0.049 101.765 0.049
201612 0.030 101.449 0.030
201703 0.017 102.634 0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merus Labs International  (NAS:MSLI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Merus Labs International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines